Gel Boosts Stem Cell Studies
News Jan 10, 2013
Scientists have developed a family of compounds that can support the growth of human embryonic stem cells on a large scale.
Their technique could have applications for use in drug testing or treatments for conditions such as such as Huntington’s and Parkinson’s diseases.
The new materials, which are water-based gels, act as a tiny scaffold to which cells can cling as they grow.
Normally cells must be grown on expensive biological surfaces that can carry risk of contamination.
Once cells have multiplied sufficiently for their intended purpose, the gels can be cooled, enabling the stem cells to drop off the scaffold without becoming damaged.
The new approach surpasses existing techniques of separating cells by mechanical or chemical means, which carry a greater risk of damage to cells.
Scientists say the materials could offer a means of enabling the stem cells to be produced in large numbers efficiently and with a lowered risk of contamination.
This could facilitate research, drug screening programmes and clinical applications that call for large numbers of cells.
Researchers at the University developed the materials by screening hundreds of potential compounds for their ability to support stem cell growth.
From a shortlist of four, one has been found to be effective, and researchers say the remaining three show similar potential.
Stem cells provide a powerful tool for screening drugs as they can be used to show the effects of drugs on cells and systems within the body.
The study, published in Nature Communications, was supported by the European Union Framework 7 Grant Funding.
The gels are being developed under licence by technology company Ilika.
Innate Reaction of Hematopoietic Stem Cells to Severe InfectionsNews
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018
EMBO Practical Course: Extracellular Vesicles: From Biology to Biomedical Applications
Apr 09 - Apr 13, 2018
EMBO | EMBL Symposium: Tissue Self-Organisation: Challenging the Systems
Mar 11 - Mar 14, 2018